Descending serotonergic controls regulate inflammation-induced mechanical sensitivity and methyl-CpG-binding protein 2 phosphorylation in the rat superficial dorsal horn.
BACKGROUND
Regulation of pain states is, in part, dependent upon plastic changes in neurones within the superficial dorsal horn. There is also compelling evidence that pain states are under the control of descending projections from the brainstem. While a number of transcription factors including Methyl-CpG-binding protein 2 (MeCP2), Zif268 and Fos have been implicated in the regulation of dorsal horn neurone sensitization following injury, modulation of their activity by descending controls has not been investigated.


RESULTS
Here, we describe how descending controls regulate MeCP2 phosphorylation (P-MeCP2), known to relieve transcriptional repression by MeCP2, and Zif268 and Fos expression in the rat superficial dorsal horn, after CFA injection into the hind paw. First, we report that CFA significantly increased P-MeCP2 in Lamina I and II, from 30 min post injection, with a maximum reached after 1 h. The increase in P-MeCP2 paralleled that of Zif268 and Fos, and P-MeCP2 was expressed in large sub-populations of Zif268 and Fos expressing neurones. Serotonergic depletion of the lumbar spinal cord with 5,7 di-hydroxytryptamine creatinine sulphate (5,7-DHT) reduced the inflammation evoked P-MeCP2 in the superficial dorsal horn by 57%, and that of Zif268 and Fos by 37.5% and 30% respectively. Although 5,7-DHT did not change primary thermal hyperalgesia, it significantly attenuated mechanical sensitivity seen in the first 24 h after CFA.


CONCLUSIONS
We conclude that descending serotonergic pathways play a crucial role in regulating gene expression in the dorsal horn and mechanical sensitivity associated with an inflammatory pain state.
Géranton
Sandrine M
SM
Department of Cell and Developmental Biology, University College London, Medawar Building, London, UK. ucgasmg@ucl.ac.uk
Fratto
Vincenza
V
Tochiki
Keri K
KK
Hunt
Stephen P
SP
D015116:5,7-Dihydroxytryptamine / Q000008:administration & dosage; D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D005620:Freund's Adjuvant / Q000008:administration & dosage; D018836:Inflammation Mediators / Q000008:administration & dosage*; D008297:Male; D051783:Methyl-CpG-Binding Protein 2 / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D020671:Posterior Horn Cells / Q000378:metabolism* / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000009:adverse effects / Q000502:physiology*; D013116:Spinal Cord / Q000378:metabolism* / Q000473:pathology*
D000276:Adjuvants, Immunologic; D018836:Inflammation Mediators; C497394:Mecp2 protein, rat; D051783:Methyl-CpG-Binding Protein 2; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D005620:Freund's Adjuvant
Science. 2008 May 30;320(5880):1224-9
18511691
Prog Neurobiol. 2002 Apr;66(6):355-474
12034378
Neuron. 2007 Nov 8;56(3):422-37
17988628
J Neurosci. 2007 Dec 19;27(51):13958-67
18094233
Pain. 1999 May;81(1-2):45-55
10353492
Nat Neurosci. 2006 Dec;9(12):1534-40
17115041
Eur J Pharmacol. 1997 Jun 18;329(1):17-26
9218679
Pain. 2004 Dec;112(3):315-323
15561387
Pain. 2004 Jul;110(1-2):259-68
15275776
Pain. 2007 Feb;127(3):253-262
16997469
J Child Neurol. 2005 Sep;20(9):736-40
16225828
Pain. 2005 Sep;117(1-2):182-92
16098671
Pain. 2006 Aug;123(3):264-274
16644129
Exp Brain Res. 2003 Mar;149(1):114-24
12592509
J Neurosci. 1997 Mar 1;17(5):1776-85
9030636
FEBS Lett. 2006 Dec 11;580(28-29):6629-34
17113581
Nat Neurosci. 2002 Dec;5(12):1319-26
12402039
Nat Neurosci. 2001 Mar;4(3):289-96
11224546
Pain. 2008 Jul;137(1):66-80
17888573
Nat Rev Neurosci. 2004 Jul;5(7):565-75
15208698
Trends Neurosci. 2002 Jun;25(6):319-25
12086751
Mol Pain. 2007 Oct 31;3:32
17974009
Neuropharmacology. 1998 Aug;37(8):1091-3
9833638
Eur J Neurosci. 2006 Aug;24(3):761-72
16930406
Prog Brain Res. 2000;129:231-42
11098693
Int J Neurosci. 2005 Jul;115(7):935-48
16051541
Nat Neurosci. 1999 Dec;2(12):1114-9
10570489
J Neurosci. 2002 Feb 1;22(3):1010-9
11826129
Trends Pharmacol Sci. 2000 Aug;21(8):284-7
10918627
Nat Rev Genet. 2006 Jun;7(6):415-26
16708070
Brain Res Brain Res Rev. 2004 Nov;46(3):295-309
15571771
Science. 1999 Nov 19;286(5444):1558-61
10567262
Neuron. 2006 Oct 19;52(2):255-69
17046689
J Neurophysiol. 1999 Nov;82(5):2649-56
10561434
Science. 2003 Oct 31;302(5646):885-9
14593183
Neuroscience. 1999 Mar;89(1):17-28
10051214
Pain. 1988 Jan;32(1):77-88
3340425
J Neurosci. 2007 Nov 28;27(48):13181-91
18045912
J Neurosci. 2007 Jun 6;27(23):6163-73
17553988
J Neurophysiol. 1997 Aug;78(2):746-58
9307109
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7687-92
10393881
Exp Brain Res. 2001 Sep;140(2):198-205
11521152
Neurosignals. 2002 Jul-Aug;11(4):224-30
12393948
Exp Neurol. 2005 Jul;194(1):255-66
15899262